Home  /  Resource Library  /  Physician considered treatment attributes for third line diffuse large B-cell lymphoma treatment decision making: Physician perspectives from a survey across Western Europe and US

Physician considered treatment attributes for third line diffuse large B-cell lymphoma treatment decision making: Physician perspectives from a survey across Western Europe and US

ESMO 2021: Study investigated factors doctor’s find important when selecting 3rd line treatment options for DLBCL.